Hologic (NASDAQ:HOLX) Sets New 1-Year Low Following Analyst Downgrade
Hologic, Inc. (NASDAQ:HOLX – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday after Leerink Partnrs downgraded the stock from a strong-buy rating to a hold ...
Hologic (HOLX) to Release Earnings on Wednesday
Hologic (NASDAQ:HOLX – Get Free Report) will likely be issuing its quarterly earnings data after the market closes on ...
Hologic outlines Q2 revenue guidance of $995M–$1.005B amid expected diagnostics growth
Q1 2025 Management View CEO Steve MacMillan announced Q1 2025 revenue of $1.022 billion, reflecting a 1% increase on a constant currency basis, aligned with the company’s guidance. Non-GAAP EPS ...